CA 125 and OA 3 as target antigens for immunodiagnosis and immunotherapy in ovarian cancer

This publication has 13 references indexed in Scilit:

• Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments
  European Journal of Nuclear Medicine and Molecular Imaging, 1989
• Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1988
• Use of statistical evaluation of antigen profiles in differential diagnosis between colonic and ovarian adenocarcinomas.
  Journal of Clinical Pathology, 1988
• An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma
  Gynecologic Oncology, 1988
• Pre-operative discrimination between benign and malignant ovarian tumors using a combination of CA125 and CA15.3 serum assays
  International Journal of Cancer, 1988
• Prognostic Factors in Borderline and Invasive Ovarian Tumours of the Common Epithelial Type
  Pathology - Research and Practice, 1987
• Use of indium-111-labeled OC-125 monoclonal antibody in the detection of ovarian cancer
  Gynecologic Oncology, 1987
• Prospects and applications of monoclonal antibodies in gynecological oncology
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1985
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983
• Reactivity of a monoclonal antibody with human ovarian carcinoma.
  Journal of Clinical Investigation, 1981